https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 Effect of baseline oestradiol serum concentration on the efficacy of anastrozole for preventing breast cancer in postmenopausal women at high risk: a case-control study of the IBIS-II prevention trial https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:53837 Wed 28 Feb 2024 15:17:37 AEDT ]]> A systematic review of decision aids for patients making a decision about treatment for early breast cancer https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:29914 Wed 11 Apr 2018 11:53:12 AEST ]]> A decision aid for women considering neoadjuvant systemic therapy for operable invasive breast cancer: development and protocol of a phase II evaluation study (ANZ1301 DOMINO) https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:23048 Wed 11 Apr 2018 11:36:49 AEST ]]> A retrospective analysis of nadir-neutropenia directed pegylated granulocyte-colony stimulating factor on febrile neutropenia rates in (neo)adjuvant breast cancer chemotherapy regimens. https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:41071 20% in TC and TCH inroutine clinical practice should guide primary GCSF use in accordance with international guidelines.]]> Wed 10 Jan 2024 11:15:37 AEDT ]]> Strategies to support shared decision making in breast cancer https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:34274 Wed 09 Mar 2022 16:03:33 AEDT ]]> Wilfully out of sight? A literature review on the effectiveness of cancer-related decision aids and implementation strategies https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:24745 Wed 06 Apr 2022 14:01:13 AEST ]]> Women's experiences with deciding on neoadjuvant systemic therapy for operable breast cancer: a qualitative study https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:32035 Wed 06 Apr 2022 13:59:50 AEST ]]> A retrospective analysis of nadir-neutropenia directed pegylated granulocyte-colony stimulating factor on febrile neutropenia rates in (neo)adjuvant breast cancer chemotherapy regimens https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:51107 20% in TC and TCH in routine clinical practice should guide primary GCSF use in accordance with international guidelines.]]> Wed 04 Oct 2023 11:54:27 AEDT ]]> What is the prevalence of fear of cancer recurrence in cancer survivors and patients? A systematic review and individual participant data meta-analysis https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:52167 Wed 04 Oct 2023 10:56:40 AEDT ]]> Optimizing care for younger women with hormone receptor-positive, HER2-negative metastatic breast cancer https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:42001 Tue 16 Aug 2022 16:44:32 AEST ]]> Single-arm longitudinal study to evaluate a decision aid for women offered Neoadjuvant systemic therapy for operable breast cancer https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:48826 Tue 09 May 2023 10:38:07 AEST ]]> A discrete choice experiment to assess cancer patients' preferences for when and how to make treatment decisions https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:34902 Tue 03 Sep 2019 17:58:13 AEST ]]> Patient-reported outcomes with neoadjuvant vs adjuvant systemic therapy for operable breast cancer https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:36683 Thu 17 Feb 2022 09:29:01 AEDT ]]> Exploring women's experiences with a decision aid for neoadjuvant systemic therapy for operable breast cancer https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:34901 Thu 09 Dec 2021 11:04:36 AEDT ]]> Aromatase inhibitor induced musculoskeletal syndrome: a significant problem with limited treatment options https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:23244 Thu 04 Nov 2021 10:39:09 AEDT ]]> Oncology patients’ and oncology nurses’ views on palliative chemotherapy: a cross-sectional comparison https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:49063 Thu 04 May 2023 08:07:12 AEST ]]> Not asking cancer patients about their preferences does make a difference. A cross-sectional study examining cancer patients' preferred and perceived role in decision-making regarding their last important cancer treatment https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:34900 Thu 03 Oct 2019 13:42:54 AEST ]]> Systemic treatment of HER2-positive metastatic breast cancer: a systematic review https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:20551 Sat 24 Mar 2018 08:02:39 AEDT ]]> Neoadjuvant chemotherapy: what does it take to tAnGo? https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:19710 Sat 24 Mar 2018 07:53:42 AEDT ]]> Supportive care of women with breast cancer: key concerns and practical solution https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:29649 Sat 24 Mar 2018 07:41:51 AEDT ]]> Curative strategies for liver metastases from colorectal cancer: a review https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:23510 Sat 24 Mar 2018 07:17:18 AEDT ]]> Exploring decision-making about neo-adjuvant chemotherapy for breast cancer (letter) https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:24782 The Breast Journal.]]> Sat 24 Mar 2018 07:14:06 AEDT ]]> The right place at the right time: medical oncology outpatients’ perceptions of location of end of life care https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:30020 Mon 30 Apr 2018 15:43:49 AEST ]]> Systemic treatment of HER2+ metastatic breast cancer: clinical conundrums and future perspectives https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:19927 Mon 06 Aug 2018 11:18:23 AEST ]]> Efficacy and safety of neoadjuvant pertuzumab plus trastuzumab in combination with chemotherapy regimen in Chinese patients with HER2-positive early breast cancer: a real-world retrospective multi-center cohort study https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:53063 Fri 17 Nov 2023 11:35:16 AEDT ]]> Facilitating High Quality Cancer Care: A Qualitative Study of Australian Chairpersons' Perspectives on Multidisciplinary Team Meetings https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:39680 Fri 17 Jun 2022 15:39:05 AEST ]]> Results of a survey of cancer patients' willingness to travel to participate in a clinical trial https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:46154 Fri 11 Nov 2022 19:05:54 AEDT ]]> Do medical oncology patients and their support persons agree about end of life issues? https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:30021 Fri 10 Mar 2023 18:45:00 AEDT ]]> Support persons' preferences for the type of consultation and the format of information provided when making a cancer treatment decision https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:34896 0.05). Our findings suggest that when making cancer treatment decisions, clinicians should consider offering patients and support persons written and online information, combined with two shorter consultations.]]> Fri 10 Mar 2023 17:39:19 AEDT ]]> Dances with denial: Have medical oncology outpatients conveyed their end-of-life wishes and do they want to? https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:34929 Fri 10 Mar 2023 17:05:03 AEDT ]]> Treatment of pancreatic insufficiency using pancreatic extract in patients with advanced pancreatic cancer: a pilot study (PICNIC) https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:34474 Fri 01 Apr 2022 09:29:15 AEDT ]]>